Other research analysts have also recently issued reports about the stock. B. Riley set a $9.00 price objective on shares of National CineMedia and gave the company a hold rating in a report on Tuesday, November 14th.
Comment?

Impax Laboratories Inc - Research analysts at SunTrust Banks issued their Q1 2018 earnings per share estimates for Impax Laboratories in a research report issued to clients and investors on Wednesday. SunTrust Banks analyst J. Boris anticipates that the specialty pharmaceutical company will post earnings per share of $0.27 for the quarter.
Comment?

Media stories about CVR Energy have trended positive recently, according to Accern Sentiment Analysis. The research firm identifies positive and negative press coverage by monitoring more than twenty million blog and news sources.
Comment?

Shares of Acer Therapeutics Inc have been assigned an average broker rating score of 1.50 from the four brokers that cover the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a hold rating and three have issued a strong buy rating on the company.
Comment?

Press coverage about Integra Lifesciences has been trending somewhat positive on Tuesday, according to Accern. The research group identifies positive and negative news coverage by reviewing more than twenty million news and blog sources in real time.
Comment?

The brokerage currently has a $18.00 price objective on the oil and gas producer's stock, down from their previous price objective of $19.00. Several other brokerages have also recently weighed in on ENLK.
Comment?

Finish Line Inc was the recipient of a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 10,600,747 shares, a growth of 17.9% from the February 15th total of 8,994,156 shares.
Comment?

Separately, Needham & Company LLC restated a "buy" rating and issued a $90.00 target price on shares of Silicom in a research note on Friday, January 12th. Silicom opened at $58.56 on Tuesday.
Comment?

NPTN has been the topic of several other research reports. Needham & Company LLC reaffirmed a strong-buy rating and set a $9.00 price target on shares of NeoPhotonics in a research report on Friday, March 2nd.
Comment?

News headlines about Teradyne have trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. The research firm ranks the sentiment of media coverage by monitoring more than 20 million news and blog sources.
Comment?

Several other equities research analysts have also issued reports on FRME. Keefe, Bruyette & Woods reaffirmed a buy rating and issued a $52.00 price objective on shares of First Merchants in a research note on Thursday, January 25th.
Comment?

A number of other research analysts also recently issued reports on CSII. Leerink Swann cut their price objective on Cardiovascular Systems from $31.00 to $30.00 and set an outperform rating for the company in a research note on Thursday, February 8th.
Comment?

Roku Inc was the recipient of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 9,946,474 shares, a growth of 39.2% from the February 15th total of 7,147,395 shares.
Comment?

Separately, Zacks Investment Research raised shares of Seres Therapeutics from a sell rating to a hold rating in a research note on Wednesday, March 7th. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and nine have issued a buy rating to the stock.
Comment?

Okta Inc was the recipient of a significant growth in short interest in February. As of February 28th, there was short interest totalling 5,234,874 shares, a growth of 34.7% from the February 15th total of 3,887,251 shares.
Comment?